Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 946364016 | 9463640 | 16 | F | 20131208 | 20160711 | 20130819 | 20160714 | EXP | PHHY2013CA088764 | NOVARTIS | 64.22 | YR | M | Y | 0.00000 | 20160714 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 946364016 | 9463640 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 946364016 | 9463640 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 946364016 | 9463640 | 3 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | 21588 | 400 | MG | QD | |||||||
| 946364016 | 9463640 | 4 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Unknown | 300 MG, QD | 21588 | 300 | MG | QD | |||||||
| 946364016 | 9463640 | 5 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 200 MG, QD | 21588 | 200 | MG | QD | |||||||
| 946364016 | 9463640 | 6 | SS | IMATINIB | IMATINIB | 1 | Unknown | UNK | 21588 | ||||||||||
| 946364016 | 9463640 | 7 | C | FERROUS FUMARATE | FERROUS FUMARATE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
| 946364016 | 9463640 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, BID | 0 | 40 | MG | BID | |||||||
| 946364016 | 9463640 | 9 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 946364016 | 9463640 | 10 | C | NOVOLIN | INSULIN HUMAN | 1 | Unknown | 15 U, QD | 0 | 15 | DF | QD | |||||||
| 946364016 | 9463640 | 11 | C | INSULIN | INSULIN NOS | 1 | Unknown | 30 U, QAM | 0 | 30 | DF | ||||||||
| 946364016 | 9463640 | 12 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 946364016 | 9463640 | 13 | C | PANTOLOC//PANTOPRAZOLE SODIUM SESQUIHYDRATE | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 946364016 | 9463640 | 1 | Chronic myeloid leukaemia |
| 946364016 | 9463640 | 6 | Product used for unknown indication |
| 946364016 | 9463640 | 7 | Product used for unknown indication |
| 946364016 | 9463640 | 8 | Product used for unknown indication |
| 946364016 | 9463640 | 9 | Product used for unknown indication |
| 946364016 | 9463640 | 10 | Product used for unknown indication |
| 946364016 | 9463640 | 11 | Diabetes mellitus |
| 946364016 | 9463640 | 12 | Product used for unknown indication |
| 946364016 | 9463640 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 946364016 | 9463640 | OT |
| 946364016 | 9463640 | HO |
| 946364016 | 9463640 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 946364016 | 9463640 | Abdominal discomfort | |
| 946364016 | 9463640 | Abdominal pain upper | |
| 946364016 | 9463640 | Anaemia | |
| 946364016 | 9463640 | Arthritis infective | |
| 946364016 | 9463640 | Blood creatinine increased | |
| 946364016 | 9463640 | Blood iron decreased | |
| 946364016 | 9463640 | Blood urea increased | |
| 946364016 | 9463640 | Chills | |
| 946364016 | 9463640 | Death | |
| 946364016 | 9463640 | Decreased appetite | |
| 946364016 | 9463640 | Device related infection | |
| 946364016 | 9463640 | Diarrhoea | |
| 946364016 | 9463640 | Dysgeusia | |
| 946364016 | 9463640 | Escherichia infection | |
| 946364016 | 9463640 | Faeces discoloured | |
| 946364016 | 9463640 | Fatigue | |
| 946364016 | 9463640 | Fluid retention | |
| 946364016 | 9463640 | Gastrointestinal haemorrhage | |
| 946364016 | 9463640 | Haematochezia | |
| 946364016 | 9463640 | Haemoglobin decreased | |
| 946364016 | 9463640 | Headache | |
| 946364016 | 9463640 | Heart rate increased | |
| 946364016 | 9463640 | Hepatic cirrhosis | |
| 946364016 | 9463640 | Hepatic failure | |
| 946364016 | 9463640 | Infection | |
| 946364016 | 9463640 | Lung infection | |
| 946364016 | 9463640 | Nausea | |
| 946364016 | 9463640 | Peripheral swelling | |
| 946364016 | 9463640 | Pyrexia | |
| 946364016 | 9463640 | Red blood cell count decreased | |
| 946364016 | 9463640 | Renal disorder | |
| 946364016 | 9463640 | Renal failure | |
| 946364016 | 9463640 | Serum ferritin increased | |
| 946364016 | 9463640 | Swelling | |
| 946364016 | 9463640 | Underdose | |
| 946364016 | 9463640 | Varicose vein | |
| 946364016 | 9463640 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 946364016 | 9463640 | 1 | 20070801 | 201306 | 0 | |
| 946364016 | 9463640 | 2 | 201308 | 20131208 | 0 | |
| 946364016 | 9463640 | 3 | 20140314 | 0 | ||
| 946364016 | 9463640 | 4 | 201507 | 0 | ||
| 946364016 | 9463640 | 6 | 201306 | 0 |